Key result
Fibrinogen uptake testing yields frequent false positives for DVT in erysipelas due to local inflammation.
Why the study?
The specificity of the 125I-fibrinogen uptake test for diagnosing deep vein thrombosis in patients with erysipelas was uncertain due to possible false positives from local inflammation.
Does the 125I-fibrinogen uptake test accurately diagnose deep vein thrombosis in patients with erysipelas of the leg?
Observational (n=43)
Does the 125I-fibrinogen uptake test accurately diagnose deep vein thrombosis in patients with erysipelas of the leg?
The 125I-fibrinogen test is too unspecific for diagnosing deep vein thrombosis in patients with erysipelas due to false positives likely caused by local inflammation.
Answers are grounded in this paper and cite their sources.
May support avoiding 125I-fibrinogen testing for DVT in erysipelas; leaves open validation of alternative diagnostics in inflammation.
The 125I-fibrinogen test was evaluated as a diagnostic tool for deep vein thrombosis in patients with erysipelas. In the investigated group of 43 patients, several showed an increased uptake that could not be verified by subsequent phlebography. The false positive test may have been caused by the local inflammatory process. The 125I-fibrinogen test seems to be too unspecific to be used for diagnosing deep vein thrombosis in this patient group.
No takes yet. Share an insight, caveat, or question.
Lindblad et al. (1988) conducted an observational in Erysipelas of the leg (n=43). 125I-fibrinogen test vs. Phlebography was evaluated on Diagnosis of deep vein thrombosis. The 125I-fibrinogen test showed low specificity for diagnosing deep vein thrombosis in patients with erysipelas, yielding false positives likely caused by local inflammation.
Synapse has enriched 10 related papers. Consider them for comparative context: